Navigation Links
'Half-match' bone marrow transplants wipe out sickle cell disease in selected patients
Date:9/20/2012

In a preliminary clinical trial, investigators at Johns Hopkins have shown that even partially-matched bone marrow transplants can eliminate sickle cell disease in some patients, ridding them of painful and debilitating symptoms, and the need for a lifetime of pain medications and blood transfusions. The researchers say the use of such marrow could potentially help make bone marrow transplants accessible to a majority of sickle cell patients who need them.

After a median follow-up of two years, the transplants successfully eliminated sickle cell disease in 11 of 17 patients. Three were fully matched to their donors and eight received half-matched donor marrow. All 11 patients are free of painful sickle cell crises and 10 no longer have anemia. There were no deaths and no unexpected toxicities.

Six of the 11 patients (all half-matched) have stopped taking immunosuppressive drugs, although some still require narcotics for chronic pain because of sickle cell-related organ damage. Blood tests on the six patients show that their red cells are now completely derived from their donor's marrow.

Patients with severe sickle cell disease (SCD) face shortened life spans, intractable pain and eventual organ damage as a result of their disease, an inherited disorder caused by a mistake in the oxygen-carrying hemoglobin molecules in red blood cells. The flawed genetic code stiffens red cells, and shapes them into a pronged "sickle" that clump and stick into blood vessel walls, cutting off blood and oxygen to tissues and organs throughout the body.

SCD occurs in approximately one in 400 African Americans, and rarely in Caucasians. An estimated 100,000 people are currently living with sickle cell disease in the U.S.

Most patients die before age 50, and many suffer poor quality of life with frequent episodes of "off-the-charts" pain, and an increased risk for kidney failure, stroke, deep-vein thrombosis, and lung disease.


'/>"/>
Contact: Vanessa Wasta
wasta@jhmi.edu
410-614-2916
Johns Hopkins Medicine
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Lack of sleep affects bone health and bone marrow activity
2. New genetic clues to why most bone marrow transplant patients develop graft-versus-host disease
3. HIV Undetectable in 2 Men After Bone Marrow Transplants: Study
4. Bone marrow transplant eliminates signs of HIV infection
5. Clinical trial seeks to cure advanced Crohns disease using bone marrow transplant
6. HIV drug reduces graft-vs.-host disease in bone marrow transplant patients, Penn study shows
7. HIV Drug May Prevent Bone Marrow Transplant Complication
8. Markey receives $6.25 million to study deadly blood and bone marrow disease
9. Fertilizing bone marrow helps answer why some cancers spread to bones
10. Noninvasive imaging technique may help kids with heart transplants
11. Protecting the hearts of those waiting for kidney and liver transplants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... million older Americans suffer from depression, often brought on ... research a project that followed the lives of ... found that Internet use among the elderly can reduce ... , "That,s a very strong effect," said Shelia Cotten, ... and media who led the project. "And it all ...
(Date:4/17/2014)... YORK April 17, 2014 EcoHealth Alliance, a ... health issues, published a comprehensive review today examining the ... Marburg virus. The review calls for improved global surveillance ... as the recent outbreak of Ebola in West Africa ... the countries of Guinea and Liberia. According to ...
(Date:4/17/2014)... uncommon these days to find a colored ribbon representing a ... cancer. But what color ribbon does one think of with ... color, for many suffering from the disease, black may be ... study consisting of lung cancer patients, primarily smokers between the ... light on the stigma often felt by these patients, the ...
(Date:4/17/2014)... TORONTO, April 17, 2014While 94 per cent of Canadians ... that screen newborns for a specific number of genetic ... willing to participate in screening that would sequence their ... prick test" in their first day or two of ... taken from their heels and tested for about five ...
(Date:4/16/2014)... the embryo. It begins as a glob of identical cells ... the cells of our lungs, muscles, nerves and all the ... feat of reverse tissue engineering, Stanford University researchers have begun ... to proliferate and transform into all of the specialized cells ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3
... Researchers have found that contacting with Age-related Macular Degeneration ... whose Body Mass Index is 30 or higher//. ... risk and high BMI (30 or higher) was associated ... risk genotype (CC) plus smoking conferred a tenfold higher ...
... transdermal system), formulated by Shire was the foremost patch ... ,Transdermal formulation of methylphenidate - DAYTRANA, is ... 10 mg, 15 mg, 20 mg and 30 mg. ... for ADHD, provides physicians and parents with a new, ...
... the National Health Service (NHS) information centre the Scots are ... and the number of NHS dentist//. ,They fear ... demand. The British Dental Association said that the NHS is ... the NHS information and statistics division, it is found that ...
... vaccines, each developed by Merck and Smith Glaxo Kline has ... cancers caused by the human papilloma viruses (HPVs). ... showed reduced infection in about 90% of the subjects. ... and immunologic technologies have contributed to the discovery of the ...
... Recent research has revealed that having several older brothers increases ... finding that adds //weight to the idea of a biological ... of Brock University in St Catharines, Canada said, "It's likely ... that there is probably a biological basis for homosexuality." ...
... and Pharmacovigilance said that FDA’s approval of REVLIMID ... the group of people suffering from multiple myeloma. ... the U.S. Food and Drug Administration (FDA) has ... (sNDA) for an additional indication for REVLIMID (lenalidomide), ...
Cached Medicine News:Health News:Cigarette Smoking and High Body Mass Index Increase the Risk of AMD 2Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 2Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 3Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 4
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) announces that ... to the announced tender offer for all of the outstanding shares ... of the waiver, the transaction is no longer conditional on OFT ... 24, 2014 following the currently scheduled expiration time, subject to the ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... , Jan. 15, 2014 MultiCell Technologies, Inc. ... a U.S. provisional patent application concerning composition of matter, ... achieve targeted tumor cell death.  This ... noncoding double stranded RNA molecules (VSRNAs) which interfere with ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Hill-Rom Holdings, Inc., (NYSE: HRC ) invites you to listen to a ... the Goldman Sachs 31st Annual Global Health Care Conference in Los Angeles ... 10:40 a.m. PDT ).     , , ... invited to listen to the live discussion via the internet link at http://ir.hill-rom.com/events.cfm ...
... June 2 Today In the Face of ... help pain management advocates expand their outreach efforts through popular ... to social media applications, such as Facebook, and walks users ... communication vehicles. Topics include "An Overview of Social Media," "Advocacy ...
Cached Medicine Technology:Hill-Rom to Participate at the Goldman Sachs 31st Annual Global Health Care Conference 2In the Face of Pain® Offers Social Media 101 for Pain Management Advocates 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: